Toshiharu Kitamura, H. Nakae, Yasuhito Irie, K. Satoh, Nobuhisa Hirasawa, Koumei Kameyama, Yuya Suzuki, Kyohei Maeno, Kenji Yoshida, M. Okuyama
{"title":"基于不良事件发生率的吉达博吉波给药安全性研究","authors":"Toshiharu Kitamura, H. Nakae, Yasuhito Irie, K. Satoh, Nobuhisa Hirasawa, Koumei Kameyama, Yuya Suzuki, Kyohei Maeno, Kenji Yoshida, M. Okuyama","doi":"10.1002/tkm2.1305","DOIUrl":null,"url":null,"abstract":"The incidence of adverse events associated with Kampo prescriptions is still unclear. We retrospectively studied the adverse events in 1104 patients prescribed jidabokuippo (JDI) to examine the safety of JDI based on adverse event rate.","PeriodicalId":23213,"journal":{"name":"Traditional & Kampo Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Safety of jidabokuippo administration based on adverse event rate\",\"authors\":\"Toshiharu Kitamura, H. Nakae, Yasuhito Irie, K. Satoh, Nobuhisa Hirasawa, Koumei Kameyama, Yuya Suzuki, Kyohei Maeno, Kenji Yoshida, M. Okuyama\",\"doi\":\"10.1002/tkm2.1305\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The incidence of adverse events associated with Kampo prescriptions is still unclear. We retrospectively studied the adverse events in 1104 patients prescribed jidabokuippo (JDI) to examine the safety of JDI based on adverse event rate.\",\"PeriodicalId\":23213,\"journal\":{\"name\":\"Traditional & Kampo Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Traditional & Kampo Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/tkm2.1305\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Traditional & Kampo Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tkm2.1305","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Safety of jidabokuippo administration based on adverse event rate
The incidence of adverse events associated with Kampo prescriptions is still unclear. We retrospectively studied the adverse events in 1104 patients prescribed jidabokuippo (JDI) to examine the safety of JDI based on adverse event rate.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
